Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study

Use of plasma DNA to detect mutations has spread widely as a form of liquid biopsy. EGFR T790M has been observed in half of lung cancer patients who have acquired resistance to EGFR tyrosine kinase inhibitors (EGFR‐TKI). Effectiveness of monitoring T790M via plasma DNA during treatment with EGFR‐TKI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Sueoka‐Aragane, Naoko, Katakami, Nobuyuki, Satouchi, Miyako, Yokota, Soichiro, Aoe, Keisuke, Iwanaga, Kentaro, Otsuka, Kojiro, Morita, Satoshi, Kimura, Shinya, Negoro, Shunichi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768390/
https://ncbi.nlm.nih.gov/pubmed/26577492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12847
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados